182 related articles for article (PubMed ID: 30214596)
1. Clinical use of trastuzumab combined with different chemotherapy regimens in multi-line treatment of advanced human epidermal growth factor receptor 2-positive gastric cancer: A case report.
Chen ZL; Zhao A; Li P; Zhang M; Yang J; Zhang L; Zhao X; Yang J; Wang L
Oncol Lett; 2018 Oct; 16(4):4614-4620. PubMed ID: 30214596
[TBL] [Abstract][Full Text] [Related]
2. Successful use of Trastuzumab with anthracycline-based chemotherapy followed by trastuzumab maintenance in patients with advanced HER2-positive gastric cancer.
Palacio S; Loaiza-Bonilla A; Kittaneh M; Kyriakopoulos C; Ochoa RE; Escobar M; Arango B; Restrepo MH; Merchan JR; Rocha Lima CM; Hosein PJ
Anticancer Res; 2014 Jan; 34(1):301-6. PubMed ID: 24403478
[TBL] [Abstract][Full Text] [Related]
3. Inetetamab combined with tegafur as second-line treatment for human epidermal growth factor receptor-2-positive gastric cancer: A case report.
Zhou JH; Yi QJ; Li MY; Xu Y; Dong Q; Wang CY; Liu HY
World J Clin Cases; 2024 Feb; 12(4):820-827. PubMed ID: 38322681
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of a patient with HER2-positive metastatic gastric cancer with third-line combination therapy with irinotecan, 5-fluorouracil, leucovorin and trastuzumab (FOLFIRI-T).
Weissinger F; Reymond M; Dumke K; Krüger M
Onkologie; 2011; 34(10):548-51. PubMed ID: 21985855
[TBL] [Abstract][Full Text] [Related]
5. [A Case of HER2-Positive Stage IV Advanced Gastric Cancer Treated with Chemotherapy Combined with Trastuzumab].
Takaya K; Takahashi R; Honma S; Horii S; Takahashi H; Hagiwara M; Chin M; Hashizume E
Gan To Kagaku Ryoho; 2016 Sep; 43(9):1113-6. PubMed ID: 27628555
[TBL] [Abstract][Full Text] [Related]
6. [Hepatic Resection of Multiple Liver Metastases from Gastric Cancer after Molecular Targeted Chemotherapy(S-1 plus Cisplatin plus Trastuzumab)].
Kim Y; Hosoda Y; Nishino M; Okano M; Kawada J; Yamasaki M; Nagai K; Yasui M; Okuyama M; Tsujinaka T
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1635-7. PubMed ID: 26805121
[TBL] [Abstract][Full Text] [Related]
7. [Progress in chemotherapy for advanced gastric cancer].
Xu RH; Teng KY
Ai Zheng; 2009 Oct; 28(10):1108-13. PubMed ID: 19799823
[TBL] [Abstract][Full Text] [Related]
8. Continuation of trastuzumab beyond disease progression in HER2-positive metastatic gastric cancer: the MD Anderson experience.
Al-Shamsi HO; Fahmawi Y; Dahbour I; Tabash A; Rogers JE; Mares JE; Blum MA; Estrella J; Matamoros A; Sagebiel T; Devine CE; Badgwell BD; Lin QD; Das P; Ajani JA
J Gastrointest Oncol; 2016 Aug; 7(4):499-505. PubMed ID: 27563438
[TBL] [Abstract][Full Text] [Related]
9. Phase II clinical trial of second-line weekly paclitaxel plus trastuzumab for patients with HER2-positive metastatic gastric cancer.
Horita Y; Nishino M; Sugimoto S; Kida A; Mizukami A; Yano M; Arihara F; Matsuda K; Matsuda M; Sakai A
Anticancer Drugs; 2019 Jan; 30(1):98-104. PubMed ID: 30124494
[TBL] [Abstract][Full Text] [Related]
10. Adding of apatinib and camrelizumab to overcome
Lv H; He Y; Nie C; Du F; Chen X
Front Pharmacol; 2022; 13():1067557. PubMed ID: 36699065
[No Abstract] [Full Text] [Related]
11. Phase II study of trastuzumab in combination with S-1 and cisplatin in the first-line treatment of human epidermal growth factor receptor HER2-positive advanced gastric cancer.
Chua C; Tan IB; Yamada Y; Rha SY; Yong WP; Ong WS; Tham CK; Ng M; Tai DW; Iwasa S; Lim HY; Choo SP
Cancer Chemother Pharmacol; 2015 Aug; 76(2):397-408. PubMed ID: 26099969
[TBL] [Abstract][Full Text] [Related]
12. Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial.
Rivera F; Romero C; Jimenez-Fonseca P; Izquierdo-Manuel M; Salud A; Martínez E; Jorge M; Arrazubi V; Méndez JC; García-Alfonso P; Reboredo M; Barriuso J; Muñoz-Unceta N; Jimeno R; López C
Cancer Chemother Pharmacol; 2019 Jun; 83(6):1175-1181. PubMed ID: 30927036
[TBL] [Abstract][Full Text] [Related]
13. Effective treatment of apatinib for chemotherapy-refractory advanced gastric carcinoma with AFP-secretion and HER2-positivity: A case report.
Ding X; Ding J
Mol Clin Oncol; 2021 Aug; 15(2):151. PubMed ID: 34141430
[TBL] [Abstract][Full Text] [Related]
14. Strategy for treatment of stage IV human epidermal growth factor 2-positive gastric cancer: a case report.
Sakaguchi M; Shimoike N; Akagawa S; Kanaya S
J Med Case Rep; 2019 Feb; 13(1):42. PubMed ID: 30791934
[TBL] [Abstract][Full Text] [Related]
15. Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial.
Gong J; Liu T; Fan Q; Bai L; Bi F; Qin S; Wang J; Xu N; Cheng Y; Bai Y; Liu W; Wang L; Shen L
BMC Cancer; 2016 Feb; 16():68. PubMed ID: 26857702
[TBL] [Abstract][Full Text] [Related]
16. [A case of unresectable HER2-positive advanced gastric cancer successfully treated by combination therapy with trastuzumab and paclitaxel].
Ojima E; Nishimura G; Nishijima K; Futagami F; Nakamura T; Hosokawa A
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2339-41. PubMed ID: 23268070
[TBL] [Abstract][Full Text] [Related]
17. Phase II Study of Neoadjuvant Anthracycline-Based Regimens Combined With Nanoparticle Albumin-Bound Paclitaxel and Trastuzumab for Human Epidermal Growth Factor Receptor 2-Positive Operable Breast Cancer.
Tanaka S; Iwamoto M; Kimura K; Matsunami N; Morishima H; Yoshidome K; Nomura T; Morimoto T; Yamamoto D; Tsubota Y; Kobayashi T; Uchiyama K
Clin Breast Cancer; 2015 Jun; 15(3):191-6. PubMed ID: 25579459
[TBL] [Abstract][Full Text] [Related]
18. [Complete Response in a Patient with HER2-Positive Gastric Cancer and Multiple Lung Metastases with Trastuzumab-Containing Chemotherapy].
Nakata W; Tokuyama N; Yagioka H; Suyama Y; Ogura K
Gan To Kagaku Ryoho; 2016 May; 43(5):625-7. PubMed ID: 27210096
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Safety of Dual Anti-HER2 Therapy in the Neoadjuvant Setting for Treatment of HER2-Positive Breast Cancer.
Yu AF; Singh JC; Wang R; Liu JE; Eaton A; Oeffinger KC; Steingart RM; Hudis CA; Dang CT
Oncologist; 2017 Jun; 22(6):642-647. PubMed ID: 28341761
[TBL] [Abstract][Full Text] [Related]
20. Multicenter phase II study of trastuzumab with S-1 plus oxaliplatin for chemotherapy-naïve, HER2-positive advanced gastric cancer.
Takahari D; Chin K; Ishizuka N; Takashima A; Minashi K; Kadowaki S; Nishina T; Nakajima TE; Amagai K; Machida N; Goto M; Taku K; Wakatsuki T; Shoji H; Hironaka S; Boku N; Yamaguchi K
Gastric Cancer; 2019 Nov; 22(6):1238-1246. PubMed ID: 31102009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
